From GlobeNewswire: 2025-02-21 12:35:28

China SXT Pharmaceutics, Inc. will undergo a share consolidation at a ratio of 1-for-8 on February 25, 2025, to meet the Nasdaq Stock Market’s minimum bid price requirement of $1.00 per share. If the Company fails to maintain compliance, there is a risk of delisting. Shareholders will receive one consolidated share for every eight shares held, with adjustments made for stock options and warrants. Shareholders with shares held through a bank or broker will have their shares automatically adjusted. For more information, visit www.sxtchina.com or contact the Company’s transfer agent, Transhare Corporation, at +1 303-662-1122.



Read more at GlobeNewswire: China SXT Pharmaceuticals, Inc. Announces Share